ADAMTS13 and thrombotic thrombocytopenic purpura: Since the determination of ADAMTS13 enzyme activity is performed in specialized centers and laboratories, requiring a significant amount of time, it has become a goal for clinicians to predict possible TTP patients in order to start the lifesaving treatment.